Head of AI and Research Data Services, Oncology Therapy Area, Research and Development
About this role
Job Description
Orion Pharma is seeking an inspiring and visionary leader to serve as Head of Artificial Intelligence and Research Data Services, guiding our global team through a pivotal phase of digital transformation.
The Head of AI and Research Data Services in R&D will define and deliver the AI strategy across Oncology and Pain portfolios, accelerating discovery, translational medicine, and clinical development through high-impact, fit-for-purpose AI/ML solutions. This is a visionary, and proven leadership role: you will set direction, build and mentor a high-performing team, and personally drive the most critical technical and executional workstreams-turning data into decisions and decisions into measurable portfolio outcomes.
You will partner deeply with Oncology and Pain R&D leaders, Biometrics/Stats, Clinical Operations, Pharmacovigilance/Safety, Regulatory, Medical Affairs, and IT to deploy robust AI products and platforms that improve target and biomarker discovery, patient stratification, trial design and execution, endpoint measurement, and evidence generation. You will establish modern AI governance and Responsible AI practices aligned with regulated R&D environments and ensure scalable adoption across the organization.
Responsibilities
- 1) Strategy & Portfolio Impact
- Define an AI roadmap for R&D aligned to Oncology and Pain portfolio priorities (e.g., precision oncology, novel modalities, pain mechanisms, endpoints, patient subtypes).
- Identify, prioritize, and deliver AI initiatives with clear value cases (time-to-decision, probability of technical success, cycle-time reduction, cost efficiency, trial success metrics).
- Establish a use-case portfolio spanning discovery → clinical → real-world evidence, ensuring a balanced mix of quick wins and strategic platforms.
- 2) Delivery of High-Value AI Use Cases
- Lead (and when needed, personally architect) AI/ML solutions such as:
- Oncology: multimodal biomarker discovery (omics +